| pubmed-article:6324585 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6324585 | lifeskim:mentions | umls-concept:C0008049 | lld:lifeskim |
| pubmed-article:6324585 | lifeskim:mentions | umls-concept:C0019360 | lld:lifeskim |
| pubmed-article:6324585 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:6324585 | lifeskim:mentions | umls-concept:C0305052 | lld:lifeskim |
| pubmed-article:6324585 | lifeskim:mentions | umls-concept:C0078049 | lld:lifeskim |
| pubmed-article:6324585 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
| pubmed-article:6324585 | lifeskim:mentions | umls-concept:C0474643 | lld:lifeskim |
| pubmed-article:6324585 | pubmed:issue | 3A | lld:pubmed |
| pubmed-article:6324585 | pubmed:dateCreated | 1984-5-4 | lld:pubmed |
| pubmed-article:6324585 | pubmed:abstractText | Varicella is a serious infection in the immunocompromised patient. Prophylaxis with varicella zoster immune globulin is known to decrease the incidence of severe varicella infection. The titers of antibody to varicella zoster virus were compared in patients who received either varicella zoster immune globulin or intravenous immune globulin, 4 ml or 6 ml/kg per dose. The titers of antibody to varicella zoster virus were comparable in each group. | lld:pubmed |
| pubmed-article:6324585 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6324585 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6324585 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:6324585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6324585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6324585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6324585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6324585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6324585 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6324585 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:6324585 | pubmed:issn | 0002-9343 | lld:pubmed |
| pubmed-article:6324585 | pubmed:author | pubmed-author:ArvinA MAM | lld:pubmed |
| pubmed-article:6324585 | pubmed:author | pubmed-author:DobkinM BMB | lld:pubmed |
| pubmed-article:6324585 | pubmed:author | pubmed-author:KoropchakC... | lld:pubmed |
| pubmed-article:6324585 | pubmed:author | pubmed-author:BudingerM DMD | lld:pubmed |
| pubmed-article:6324585 | pubmed:author | pubmed-author:WittekA EAE | lld:pubmed |
| pubmed-article:6324585 | pubmed:author | pubmed-author:AmylonM DMD | lld:pubmed |
| pubmed-article:6324585 | pubmed:author | pubmed-author:ParyaniS GSG | lld:pubmed |
| pubmed-article:6324585 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6324585 | pubmed:day | 30 | lld:pubmed |
| pubmed-article:6324585 | pubmed:volume | 76 | lld:pubmed |
| pubmed-article:6324585 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6324585 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6324585 | pubmed:pagination | 124-7 | lld:pubmed |
| pubmed-article:6324585 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:meshHeading | pubmed-meshheading:6324585-... | lld:pubmed |
| pubmed-article:6324585 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6324585 | pubmed:articleTitle | Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin. | lld:pubmed |
| pubmed-article:6324585 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6324585 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6324585 | lld:pubmed |
